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cardiovascular system appears early in the septic shock. The aim of this project was 
to determine the role of the endocardial endothelium (EE) in the cardiac β-adrenergic 
(β-AR) dysfunction at the early phase of septic shock.
Twelve weeks-old Sprague Dawley rats received either 5 mg.kg-1 of lipopoly-
saccharide (LPS) or saline (C) intravenously. 3h later, β-AR cardiac contractility 
was evaluated on papillary muscle with or without a functional EE. EE removal was 
performed with immersion in Triton X-100 at 0.5% during 3s and was validated by 
electronic microscopy and functional studies.
Surprisingly, isoproterenol (non-selective β-AR agonist) induced contractility was 
strongly increased in papillary muscle from LPS rat (+102±19% vs C; p<0.05). A similar 
increase was observed with a β1-AR stimulation (+90±25% vs C; p<0.05) whereas 
β2-AR and β3-AR produced similar contractility both in C and LPS muscles. The EE 
removal did not modifi ed β1-AR-induced contractility in C whereas it abolished the 
increased β1-AR response in LPS. In LPS papillary muscle, the increased β1-AR-induced 
contractility was not modifi ed by pretreatment with 1 μM L-NMMA, a NO synthase 
inhibitor, or 10 μM bosentan, an endothelin receptor antagonist. Conversely, the 
increased β1-AR-induced contractility was abolished by 10 μM indomethacin, a non 
selective cyclooxygenase (COX) inhibitor, as well as by selective inhibitors of COX1 
(SC560, 3 μM) and COX2 (NS398, 3 μM).
Our results demonstrate the EE involvement in the increased cardiac β1-AR 
contractility at the early phase of endotoxemic shock. This effect is mediated through 
the activation of both COX1 and COX2 which appear as new putative therapeutic 
targets at the early phase of septic shock.
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Background: The mineralocorticoïd receptor (MR) and its ligand, aldosterone 
(aldo), are involved in cardiac diseases. Deleterious consequences of enhanced mine-
ralocorticoid signaling has been highlighted by clinical trials showing a better survival 
amoung patients with heart failure treated with MR antagonists. Cardiomyocyte-MR 
regulated processes leading to these injuries are still unclear.
Objective: To identify new aldo-MR regulated functions and genes possibly 
involved in cardiac diseases.
Methods: Transgenic mice overexpressing MR in cardiomyocytes (MR-Cardio) and 
their control littermates (Ctrl) were treated for 7 days either with aldo (60 μg/kg/day) 
or vehicle (physiological serum), and a genome microarray analysis was performed.
Results: Microarray analysis on heart of MR-Cardio and Ctrl mice. 165 genes 
were up-regulated by both aldo and MR overexpression. Connective tissue growth factor 
(CTGF) was one of the most aldo-MR regulated genes. Validation of CTGF by qPCR 
analysis in heart of mice: CTGF expression was increased in MR-Cardio-vehicule mice 
versus Ctrl-vehicule mice (×3; p<0.05) and further by aldo (×2.5; MR-Cardio+aldo 
vs MR-cardio-vehicle; p<0.05). The immuno-staining of heart sections showed that 
CTGF was produced specifi cally by cardiomyocytes. In H9C2-MR+ cell line, aldo 
induced a dose-dependent increase of CTGF expression (×2.5; p<0.05), prevented 
by MR antagonist spironolactone. A Gene ontology analysis was realized on the 
genes from microarray to identify the biological processes modulated by aldo-MR 
complex. 70 % of thes genes were involved in cell cycle. Cellular proliferation: The 
immuno-staining showed an increase of endothelial cells proliferation by aldo on the 
heart of MR-Cardio mice (Ki-67 and caveolin-1 co-localized).
Conclusion: Our results show two roles of the aldo-MR complex in the heart: 
the regulation of CTGF expression in cardiomyocytes by aldo via MR activation and 
the increase of cardiac endothelial cells proliferation.
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People with heart failure (HF) are particularly sensitive to outdoor air quality as 
assessed by the increased risk of hospital cardiac readmission and mortality during 
peak pollution. Here, we explored the mechanisms underlying the increased cardiac 
sensitivity of HF patients following chronic exposure to carbon monoxide (CO), an 
ubiquitous environmental pollutant (second-hand smoke, vehicular exhaust, industrial 
emissions...).
Seven weeks after coronary artery ligation, rats were exposed to CO in an airtight 
exposure container for 4 weeks to reproduce air quality variations environmentally 
relevant.
We found that exposure of myocardial infarcted (MI) rats to CO exacerbated the 
MI-associated cardiac remodelling, resulting in increased occurrence of ventricular 
tachycardia and in vivo contractile dysfunction. The cellular origin for the aggravation 
of HF phenotype involved a remodeling of both Ca2+ handling (Ca2+transient) and 
contractile machinery properties. The β-adrenergic reserve has been investigated both 
in vivo and in vitro. It was altered in MI animals, as expected, but was not worsened 
by chronic CO exposure. 
In addition the altered mitochondrial metabolism and the pre-existent oxidative 
stress in MI rats were more pronounced after CO exposure. Acute antioxidant treatment 
with N-acetylcysteine reversed some of the MI-induced and CO-induced alterations 
at the cellular level, therefore suggesting potential benefi cial effects of antioxidant 
strategies. Moderate exercise training performed in standard fi ltered air attenuated cardiac 
remodelling and prevented the additional lesions induced by chronic CO exposure. 
The present study shows that chronic exposure to low CO levels mimicking urban 
atmospheric pollution potentiates and worsens HF-associated cardiac remodelling, 
thus providing an explanation for epidemiological reports. Since oxidative stress is 
involved in the deleterious effects of CO pollution, antioxidant therapy or mild exercise 
could provide cellular protection against pollution effects. 
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cardiac contractility through the cyclooxygenases pathway at the early 
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The endothelial dysfunction plays an important role in the cardiovascular alterations 
during the septic shock. In addition the impaired sympathetic regulation of the 
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Methods and Results: Balb/c nude mice underwent injection of tumor cells at 
D0. Nude mice without tumor injection served as control group. CCi mice lost weight 
overtime but no signifi cant difference of the heart/body weight ratio was observed 
between both groups. At D28, extensor digitorum longus (EDL) and hearts from 
both groups were collected to assess intracellular calcium (Ca2+) imaging coupled 
with sarcomere length measurement. Studies were performed in basal condition or 
with β-adrenergic agonist, Isoproterenol (Iso). At the cellular level, EDL fi bers from 
CCi mice exhibited a signifi cant increase of spontaneous Ca2+ sparks frequency 
compared to control mice, suggesting SR Ca2+ release channels (ryanodine receptor 
1, RyR1) remodeling. Freshly isolated CCi cardiomyocytes exerted an increase of 
Ca2+ re-uptake (434±26 vs 559±37 ms, p<0.05), Ca2+ transient amplitude and SR- Ca2+ 
content (respectively 65%, p<0.05 and 68%) vs control cells. Moreover, diastolic 
Ca2+ ratio was increased in CCi cells (0.67±0.005 vs 0.65±0.004; p<0.05). That is 
consistent with a signifi cant increase of Ca2+ sparks occurrence revealing Ca2+ leak 
through cardiac RyR2. Besides, CCi cells with Iso showed increased diastolic Ca2+ 
waves (80% arrhythmic cells vs 20% in control cells). At the sarcomere level, CCi cells 
showed increased contraction amplitude (0.04±0.009 vs 0.014±0.003 μM, p<0.05). 
Conclusion: Cachexia induced modifi cations of Ca2+ handling both in skeletal 
muscle and cardiac cells. It enhanced ECC, presumably to compensate muscle 
weakness and defective inotropy, which promoted arrhythmogenic susceptibility 
under adrenergic stimulation. 
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Background: Neutrophil Gelatinase Associated Lipocalin (NGAL) is a circulating 
protein, member of the lipocalin family, which binds MMP9 and modulates its stability 
and activity. We have recently shown that NGAL is a primary target of aldosterone/
mineralocorticoid receptor (MR) in endothelial cells, vascular smooth muscle cells 
and cardiomyocytes. 
Objective: We hypothesized that NGAL could be a mediator of aldosterone/MR 
profi brotic and proinfl ammatory effects in the cardiovascular system.
Methods: Wild type (WT) and NGAL Knock Out (KO) mice were subjected 
to an uni-nephrectomy aldosterone salt challenge (NAS, 200 μg/kg/day of aldo, 1% 
NaCl in tap water) for 4 weeks. Blood pressure (SBP) was measured by tail cuff 
method. Vascular reactivity was assessed by wire myograph. Cardiovascular fi brosis 
and infl ammation were analyzed by RT-PCR, western blot, immunohistochemistry 
and ELISA.
Results: There was no difference in SBP between transgenic mice compared to 
WT mice in basal condition. With NAS challenge, SBP was increased only in WT. 
Ex vivo aortic contraction induced by phenylephrine (Phe) and potassium chloride 
(KCl) were increased by NAS challenge in WT and KO. Responses to vasodilators 
(acetylcholine and sodium nitroprussiate) were altered in NAS condition in both groups. 
Quantifi cation of pro collagen I N-terminal peptide (PINP) in plasma showed an increase 
of PINP due to NAS treatment in WT that was prevented by NGAL inactivation. In 
myocardium, NAS treatment increased collagen type I and perivascular fi brosis in 
WT whereas KO were resistant to fi brosis. In aorta, collagen type I, vascular fi brosis 
and osteopontin were also increased by NAS in WT. These increases were prevented 
by NGAL inactivation.
Conclusion: Our results show that NGAL plays a role in aldosterone/MR-mediated 
vascular fi brosis and infl ammation, but not in cardiac interstitial fi brosis and vascular 
dysfunction. We suggest that NGAL could be a new biotarget in cardiovascular fi brosis.
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Introduction The extracellular matrix protein tenascin C (TnC) is highly expressed 
during embryogenesis. In adult tissues, TnC is not expressed under physiologic 
conditions but strongly induced in infl amed and remodeled tissues. Growing evidence 
linked TnC with development and complications of cardiovascular disease. We 
hypothesized that the absence of TnC would protect the heart from pressure overload 
induced cardiac dysfunction.
Methods: Transverse aortic constriction (TAC) or Sham operations were performed 
in male C57BL/6N wild type (WT) and TnC knockout (KO) mice. After 1 or 6 weeks, 
echocardiographic measurements of left ventricular (LV) parameters and standard 
methods for cardiac gene expression, collagen coloration and immunolocalization 
were employed.
Results: In WT mice, TAC led to re-expression and protein deposition of TnC with 
a peak after 1 week (6.5% of heart surface vs 0% in Sham). Echocardiographic measure-
ments after 6 weeks of TAC exhibited signifi cantly increased of ventricular hypertrophy 
in both WT+TAC and KO+TAC compared to Sham (LV posterior wall dimension 
WT+TAC:0.102±0.006 vs Sham: 0.078±0.003cm, p<0.01; KO+TAC:0.092±0.002 
vs Sham:0.072±0.005 cm, p<0.5). However, cardiac dilation induced by TAC was 
observed in WT but not in KO (LV internal diastolic dimension; WT+TAC: 0.487±0.012 
vs Sham: 0.375±0.009cm, p<0.001; KO+TAC 0.430±0.011 vs Sham 0.407±0.011). 
Myocardial contractility was also less reduced in KO+TAC than in WT+TAC (fractional 
shortening 23.4±1.5 vs 13.9±2 %, p<0.001). In parallel, collagen deposition was lower 
in KO+TAC than in WT+TAC. Strikingly, up regulation of infl ammatory cytokines 
genes induced by TAC in WT was completely abolished in KO. Heart deposition 
of TnC was clearly colocalized with area enriched in leukocyte cell marker and the 
deletion of TnC prevented macrophage recruitment induced by TAC.
Conclusion: The absence of TnC attenuates the development of heart failure 
through possibly down regulation of infl ammatory response
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Aim: Cancer cachexia is associated with progressive loss of weight caused by 
malignant tumor growth leading to major impairment of muscular function (i.e. muscle 
weakness) due to atrophy. However, less is known about cardiac excitation-contraction 
coupling (ECC). Our objective was to evaluate ECC in a cancer-cachexia-induced 
(CCi) mouse model.
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p<0.01), in the absence of changes in cardiac fi brosis (% collagen density ctrl 1.23±0.33, 
n=5; VS MCMR-/- 1.40±0.31, n=4, ns).
Coronary endothelial dysfunction was assessed ex vivo testing the NO-mediated 
response to acetylcholine. In sham-operated animals, no difference between VS 
MCMR-/- mice and littermate controls were observed (maximal relaxation ctrl 91±1, 
n=5; VS MCMR-/- 83±2%, n=4, ns). CHF was associated with reduced response to 
Ach, indicating endothelial dysfunction, which was less severe in VS MCMR-/- mice 
(ctrl 30±3, n=4; VS MCMR-/- 54±2%, n=4, p<0.01].
Finally, coronary reserve was measured by MRI as the difference between basal 
and maximal LV perfusion obtained after stimulation by the A2a adenosinergic agonist 
ATL307. In sham-operated mice, MR deletion in VS MC resulted in a higher coronary 
reserve, (ctrl 3.4±0.9, n=4; VS MCMR-/- 6.7±1.4 mL.mg-1.min-1, n=4, p=0.10). In 
CHF mice, VS MC MR defi ciency was associated with an increased basal coronary 
perfusion (ctrl 10.5±0.41; VS MCMR-/- 12.0±0.5 mL.mg-1.min-1, p<0.05), probably 
responsible for the observed decrease in coronary reserve (ctrl 4.5±0.7, n=12; VS 
MCMR-/- 1.5±0.6 mL.mg-1.min-1, n=9, p<0.01).
These results suggest that MR deletion in VS MC improves coronary endothelial 
function and cardiac perfusion, and this is associated with reduced cardiac dysfunction 
in this model of CHF.
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Chronic heart failure (CHF) induces endothelial dysfunction, however the direct 
link between this dysfunction and aggravation of CHF is not demonstrated. We 
previously described a new treatment of CHF, based on inhibition of protein tyrosine 
phosphatase 1B (PTP1B), which both increases NO production (via restored PI3K/
Akt/eNOS signaling) and reduces adverse Left Ventricular (LV) remodeling and LV 
dysfunction. To address the direct link between endothelial protection and reduction 
of CHF, we evaluated in mouse CHF (left coronary ligation) the effects of endothelial 
PTP1B defi ciency (endoPTP1B-/- mice, obtained by crossing LOX-P PTP1B mice 
with mice expressing CRE under the control of the endothelial promoter Tie2). 
Wild type (WT) CHF mice showed markedly impaired flow-mediated, 
NO-dependent dilatation of isolated mesenteric arteries (sham: 40±4%; CHF: 5±5; 
p<0.01), which was improved in endoPTP1B-/- mice (30±5%; p<0.01 vs WT CHF).
WT CHF mice had increased LV diameters and decreased LV fractional shor-
tening (at 3 months: sham: 49±2; CHF: 12±1%; p<0.01), which were improved 
in endoPTP1B-/- mice (20±2%; p<0.01). LV pressure-volume curves showed that 
endoPTP1B-/- mice with CHF had reduced LV end-systolic (sham: 22.5±1.2%; CHF 
WT: 14.9±1.9%, p<0.05) and increased end-diastolic pressure-volume relationships 
(sham: 2.1±0.9%; CHF WT: 4.9±0.7%, p<0.05) demonstrating impaired systolic and 
diastolic dysfunction, respectively, which were both improved in endoPTP1B-/- mice 
(end-systolic: 20.6±2.3%, p>0.05; end-diastolic: 2.3±0.9%, p<0.05). Histological 
analysis showed cardiomyocyte hypertrophy and increased collagen density in WT 
CHF, which were reduced in endoPTP1B-/- mice, at identical infarct size.
Thus, endoPTP1B defi ciency not only induced an improvement of endothelial 
function, but also improved cardiac function and reduced adverse LV remodeling. 
These results provide a direct demonstration of the benefi cial effect of endothelial 
protection in the treatment of CHF.
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Background: To determine the long-term incidence of cardiac life-threatening 
complications and death in patients with the m.3243A>G, and to identify cardiac 
prognostic factors.
Methods: We retrospectively included patients carrying the m.3243A>G mutation 
who were admitted to the Neuromuscular Disease Clinic of Pitié Salpêtrière Hospital 
between January, 1992 and December, 2010. We collected information relative to their 
yearly neurological and cardiac investigations, their mutation load in blood, urine and 
muscle at initial admission, and the occurrence of cardiac life-threatening adverse 
events and death during follow-up.
Results: Forty-one patients (median age=47 years [36-55], men=13) were included, 
of whom 38 had clinical manifestations of MELAS and 3 were asymptomatic. One 
patient had a personal history of cardiac transplantation. Cardiac investigations displayed 
left ventricular hypertrophy, left ventricular dysfunction, or both abnormalities in 
18 patients, along with Wolff Parkinson White syndrome in 7, conduction system 
disease in 4, and atrial fi brillation in 1. Over a median 5-year [3-9] follow-up period, 
11 patients died, including 3 due to heart failure; 7 had life-threatening adverse 
events, including 6 hospitalizations for severe heart failure and 1 resuscitated cardiac 
arrest. By multivariate analysis, left ventricular hypertrophy was the only parameter 
independently associated with occurrence of cardiac adverse events. 
Conclusion: Patients with the m.3243A>G mutation have a high incidence of 
cardiac death and life-threatening adverse events. Left ventricular hypertrophy was 
the only parameter independently associated with occurrence of these events.
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MR deletion in cardiomyocytes improves cardiac remodeling and function in CHF, 
however the specifi c role of vascular MR in CHF remains unknown. Thus, the vascular 
and cardiac consequences of MR deletion specifi cally in vascular smooth muscle cells 
(VS MCMR-/-) were studied in mice with CHF (2months coronary artery ligation).
Invasive left ventricular pressure-volume curves showed that VS MCMR-/- CHF 
mice had increased LV end-systolic pressure-volume relationships (elastance; ctrl 
11.9±0.5, n=7; VS MCMR-/- 19.9±2.5, n=6, p<0.05) and decreased LV end-diastolic 
pressure-volume relationships (compliance; ctrl 4.08±0.45; VS MCMR-/- 2.16±0.33, 
